InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by M. Schaeffer, Director. Director active across 1 companies, notably Vivoryon Therapeutics N.V.. Aggregated, 9 disclosures have been published. The latest transaction was disclosed on 17 April 2026 — Purchase. Regulator: AFM. All data is free.
Declarations9 total
0150,000 shares0
Optie
AFM:192625·
Ideal exit: 12 Jan 2027 (T+270)
075,000 shares0
Optie
AFM:171766·
Ideal exit: 10 Dec 2025 (T+270)
0120,000 shares0
Optie
AFM:159529·
Ideal exit: 3 Mar 2025 (T+270)
€7,734-3,867 shares@ €2.000.021% mcap100.0% of flow
Gewoon aandeel
AFM:155125·
090,000 shares0
Optie
AFM:152998·
Ideal exit: 6 Oct 2024 (T+270)
040,000 shares0
Optie
AFM:144118·
Ideal exit: 5 Sept 2023 (T+270)
0150,000 shares0
Optie
AFM:144117·
Ideal exit: 20 Jan 2023 (T+270)
0236,775 shares0
Optie
AFM:144116·
Ideal exit: 31 Aug 2021 (T+270)
03,867 shares0
Gewoon aandeel
AFM:104867·
Ideal exit: 27 Aug 2021 (T+270)
9 of 9 declarations
About M. Schaeffer
M. Schaeffer is a board member of Vivoryon Therapeutics N.V., a company specializing in the development of therapeutic treatments. He contributes to the strategic direction of the company and oversees its operations. His expertise in the biopharmaceutical field is an asset for Vivoryon.
